Related Experiment Video
Updated: Jun 26, 2026
07:30
A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact
Published on: September 21, 2017
Approaches for the unimmunised--one size does not fit all
1Centre for Epidemiology and Biostatistics, UCL Institute of Child Health, London.
The Journal of Family Health Care
|December 31, 2008
Summary
Most children complete their vaccinations, but some do not. Understanding the diverse reasons for incomplete childhood immunizations is key to developing targeted strategies that maximize vaccine uptake.
Area of Science:
- Pediatrics
- Public Health
- Immunization
Background:
- Childhood vaccination is crucial for preventing infectious diseases.
- While most children complete their vaccination schedule, a significant proportion do not.
- Reasons for incomplete immunization are varied and complex.
Purpose of the Study:
- To analyze the reasons behind incomplete childhood vaccination.
- To identify effective strategies for improving vaccination rates.
- To inform public health efforts aimed at maximizing childhood immunization uptake.
Main Methods:
- Review of existing research on vaccination patterns.
- Analysis of diverse factors influencing vaccine completion.
- Identification of successful intervention strategies.
Main Results:
- Vaccination completion rates vary significantly.
- Multiple socioeconomic, cultural, and access-related factors impact uptake.
- Targeted interventions show promise in increasing immunization rates.
Conclusions:
- Addressing the diverse reasons for incomplete vaccination is essential.
- Strategic, evidence-based approaches are needed to improve childhood immunization coverage.
- Further research can refine targeted strategies for maximum impact.
Related Concept Videos
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:22PPE Use in Healthcare Settings I: Donning
Donning PPE must be completed before contact with the patient. This process protects from infectious agents. The sequence and action included in each donning are critical, and the steps must be systematic to avoid exposure to pathogens. The institutional policy also needs to be followed while donning PPE. The pre-donning preparations are gathering equipment, inspecting the PPE equipment for tears, holes, or damage, removing jewelry, removing any garments below the elbows, and tying the hair...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
01:10PPE Use in Healthcare Settings II: Doffing
The sequence of removing or doffing PPE starts with the gloves, as they are the most contaminated. Next is removal of the face shield or goggles, as they would interfere with removing other PPE. Then remove the gown, followed by the mask or respirator. Perform hand hygiene between steps if hands become contaminated and immediately after removing all PPE. Generally, the outside front and sleeves of the isolation gown, the goggles or the mask, the respirator, and the face shield are contaminated.